NGM BIOPHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
08 Nov 2023	Form 3: Viret Jean-Frederic, Chief Financial Officer Holds 38 shares of Common Stock
18 Sep 2023	Form 3: Perlich Irene, Principal Accounting Officer Holds 10,000 shares of Common Stock
10 Jun 2021	Form 3: Perlmutter Roger M, Director Holds 0 shares of Common Stock
10 Mar 2021	Form 3: Pierce Valerie L, SVP, GC & CCO Holds 3,610 shares of Common Stock
15 Jul 2020	Form 3: Nolan Mangini Siobhan, Chief Financial Officer Holds 0 shares of Common Stock
09 Jun 2020	Form 3: Ho Carole, Director Holds 0 shares of Common Stock
14 Apr 2020	Form 3: Lieu Hsiao D, SVP, Chief Medical Officer
05 Dec 2019	Form 3: Guyer Shelly D, Director No securities owned
11 Oct 2019	Form 3: Column Group III, Lp, 10% owner and 2 others Holds 53,172 shares of Common Stock
09 Apr 2019	Form 3: Ponoi CAPITAL, Lp, 10% owner and 4 others Holds 1,875,000 shares of Common Stock
03 Apr 2019	Form 3: Svennilson Peter, Director Holds 475,957 shares of Common Stock
03 Apr 2019	Form 3: Goeddel David V, Director Holds 475,957 shares of Common Stock
03 Apr 2019	Form 3: Schnell David, Director
03 Apr 2019	Form 3: Hooper Suzanne Sawochka, Director
03 Apr 2019	Form 3: Rieflin William Jl, Director Holds 2,712,500 shares of Common Stock
03 Apr 2019	Form 3: Leschly Mark, Director
03 Apr 2019	Form 3: Chen Jin-long, Director Holds 924,943 shares of Common Stock
03 Apr 2019	Form 3: Tichenor Mchenry T, Director Holds 38,982 shares of Common Stock
03 Apr 2019	Form 3: Woodhouse David J, Director Holds 80,000 shares of Common Stock
03 Apr 2019	Form 3: Trombley Aetna Wun, President & COO

Comments